PRVA

Privia Health Group, Inc.

NasdaqGSUSDEQUITY DELAYED

21.24

▲ 0.04 (0.19%)

MARKET · —

Price

Open

21.22

Prev close

21.20

Day high

21.35

Day low

21.04

Volume

904.06K

Market cap

—

P/E (TTM)

—

52W range

19.53 – 28.82

Trailing performance

Price return · vs SPY

Returnvs SPY

-4.00% -2.6%

-15.42% -19.1%

-6.71% -9.8%

-3.96% -15.0%

YTD

-10.92% -23.2%

-0.14% -20.1%

-18.71% -92.9%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

21.65

-1.88% from price

SMA 20

22.68

-6.88% from price

SMA 50

24.50

-13.78% from price

SMA 100

23.68

-10.31% from price

SMA 200

23.40

-9.73% from price

EMA 12

21.96

-3.26% from price

EMA 26

22.98

-7.59% from price

EMA 50

23.58

-9.92% from price

RSI (14)

27.9

Oversold

MACD (12,26,9)

-1.03

Hist -0.11

ATR (14)

0.93

4.40% of price

Realised vol 30D

33.4%

Annualised

Bollinger upper

25.11

20, 2σ

Bollinger lower

20.25

20, 2σ

50 / 200 cross

Golden

24.50 vs 23.40

Trend bias

Below 200

-9.73%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.63

Less volatile than market

Correlation to SPY

0.25

Largely independent

Realised vol 30D

33.4%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-24.8%

Peak to trough

Max drawdown 5Y

-62.6%

Peak to trough

ATR 14

0.93

4.40% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 21.24

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

PRVA · links out to the publisher

Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings? StockStory · 2d ago Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors GlobeNewswire · 4d ago The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call StockStory · 7d ago Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace? Insider Monkey · 9d ago Privia Health (PRVA) Q2 2026 Earnings Call Transcript Motley Fool · 9d ago PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus StockStory · 12d ago Privia Health Group (PRVA) Is Down 5.2% After Raising 2026 Revenue Guidance And Expanding Footprint Simply Wall St. · 13d ago Privia Health Group Q2 Earnings Call Highlights MarketBeat · 15d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.